Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Common Equity: 2022

  • ADC Therapeutics' Common Equity was N/A to $79.5 million in Q4 2022 from the same period last year, while for Dec 2022 it was $79.5 million, marking a year-over-year change of. This contributed to the annual value of $79.5 million for FY2022, which is N/A change from last year.
  • As of Q4 2022, ADC Therapeutics' Common Equity stood at $79.5 million.
  • In the past 5 years, ADC Therapeutics' Common Equity registered a high of $79.5 million during Q4 2022, and its lowest value of $79.5 million during Q4 2022.
  • Over the past 1 years, ADC Therapeutics' median Common Equity value was $79.5 million (recorded in 2022), while the average stood at $79.5 million.